TO properly address and manage concerns surrounding the effects on the use of the Dengvaxia vaccine including its apparent harmful results to children who received the vaccination, Department of Health (DOH) Secretary Francisco T. Duque appointed DOH-CALABARZON (Cavite, Laguna, Batangas, Rizal, Quezon) Regional Director Eduardo C. Janairo as Chair of the National Dengvaxia Task Force for CALABARZON, Central Luzon and Metro Manila as part of health care provider network under the Universal Health Care Framework.
“We need to harmonize efforts and provide similar services and activities, support and assistance for the three regions. Basically, Kung ano ang ginawa namin sa CALABARZON ito ang susundin namin for the two regions. Kailangang hanapin natin lahat ng nabakunahan. Bigyan ng physical examination, bantayan at palakasin ang kanilang mga resistensya dahil ito lamang ang makapagbibigay ng proteksyon sa anumang sakit na pwedeng dumapo sa kanila,” Regional Director Eduardo C. Janairo stated.
“Kailangan nating magkaroon ng vaccine and patient tracking kasama na dito ang referral system dahil kailangan natin silang i-profile at bantayan upang malaman kung anuman ang mangyari sa kanila sa loob ng limang taon mula ng sila ay mabakunahan. Lahat ay hahanapin natin at walang dapat maiiwan,” he added.
Under the Department Personnel Order No. 2019-2458 dated June 10, 2019, DOH established the Task Force for Regions CALABARZON, Central Luzon and Metro Manila to address the Tetravalent Dengue vaccination concerns.
Janairo explained that the objective of the National Task Force is to establish a whole of government and whole of society management team to oversee the implementation of activities for more equitable provision of services for all the regions concern.
In 2016, the DOH launched the Dengvaxia immunization and was implemented in the three regions including region 7 as requested by its congressional representative. In 2017, it created panic and concern among the parents of children who received the vaccine because of the analysis and announcement made by its manufacturer.
A total of about 833,000 Filipino children were given the controversial Dengvaxia vaccine.
“It is equally important to recommend funding for the purpose of establishing a research agenda for this purpose to find out if there really is a correlation between the Dengvaxia vaccine and the reported deaths allegedly caused by the vaccine because as of now wala pa rin talagang makakapagsabi kung mayroon nga itong kinalaman,” Janairo disclosed. |-BNN
